Hjem › Interstitielle lungesykdommer › Alabama › Birmingham
Kliniske studier for Interstitielle lungesykdommer i Birmingham, AL
9 studier for Interstitielle lungesykdommer søker deltakere på steder i og rundt Birmingham (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
RekruttererFase 3
- University of Alabama at Birmingham, Birmingham
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RekruttererFase 2
- University of Alabama, Birmingham
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
RekruttererFase 2
- UAB Lung Health Center, Birmingham
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Rekrutterer
- University of Alabama at Birmingham, Birmingham
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RekruttererObservasjonsstudie
- University of Alabama at Birmingham, Birmingham
Platform Clinical Study for Conquering Scleroderma
RekruttererFase 2
- University of Alabama - Division of Pulmonary and Critical Care Medicine, Birmingham
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
RekruttererObservasjonsstudie
- University of Alabama - Birmingham, Birmingham
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
RekruttererFase 3
- UAB Lung Health Center, Birmingham
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
RekruttererFase 2
- University of Alabama at Birmingham, Birmingham
Interstitielle lungesykdommer-studier i andre byer
- New York City, NY18 studier
- Philadelphia, PA16 studier
- Los Angeles, CA14 studier
- Kansas City, KS13 studier
- Durham, NC13 studier
- Charleston, SC13 studier
- Chicago, IL12 studier
- Houston, TX12 studier
- Ann Arbor, MI11 studier
- Aurora, CO11 studier
- Phoenix, AZ9 studier
- Salt Lake City, UT9 studier
Andre studier i Birmingham
- Kreft (alle typer)30 studier
- Brystkreft24 studier
- Fedme23 studier
- Eggstokkreft23 studier
- Ikke-småcellet lungekreft22 studier
- Akut myelogen leukemi21 studier
- Multipelt myelom18 studier
- KOLS17 studier
- Kardiovaskulær sykdom17 studier
- Overvekt16 studier
- Endometriekreft16 studier
- Type 2-diabetes16 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.